FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283069360> ?p ?o ?g. }

• W4283069360 abstract "Clarithromycin may act as immune-regulating treatment in sepsis and acute respiratory dysfunction syndrome. However, clinical evidence remains inconclusive. We aimed to evaluate whether clarithromycin improves 28-day mortality among patients with sepsis, respiratory and multiple organ dysfunction syndrome.We conducted a multicenter, randomized, clinical trial in patients with sepsis. Participants with ratio of partial oxygen pressure to fraction of inspired oxygen less than 200 and more than 3 SOFA points from systems other than the respiratory function were enrolled between December 2017 and September 2019. Patients were randomized to receive 1 gr of clarithromycin or placebo intravenously once daily for 4 consecutive days. The primary endpoint was 28-day all-cause mortality. Secondary outcomes were 90-day mortality; sepsis response (defined as at least 25% decrease in SOFA score by day 7); sepsis recurrence; and differences in peripheral blood cell populations and leukocyte transcriptomics.Fifty-five patients were allocated to each arm. By day 28, 27 (49.1%) patients in the clarithromycin and 25 (45.5%) in the placebo group died (risk difference 3.6% [95% confidence interval (CI) - 15.7 to 22.7]; P = 0.703, adjusted OR 1.03 [95%CI 0.35-3.06]; P = 0.959). There were no statistical differences in 90-day mortality and sepsis response. Clarithromycin was associated with lower incidence of sepsis recurrence (OR 0.21 [95%CI 0.06-0.68]; P = 0.012); significant increase in monocyte HLA-DR expression; expansion of non-classical monocytes; and upregulation of genes involved in cholesterol homeostasis. Serious and non-serious adverse events were equally distributed.Clarithromycin did not reduce mortality among patients with sepsis with respiratory and multiple organ dysfunction. Clarithromycin was associated with lower sepsis recurrence, possibly through a mechanism of immune restoration. Clinical trial registration clinicaltrials.gov identifier NCT03345992 registered 17 November 2017; EudraCT 2017-001056-55." @default.
• W4283069360 created "2022-06-19" @default.
• W4283069360 creator A5002694006 @default.
• W4283069360 creator A5005343190 @default.
• W4283069360 creator A5015751415 @default.
• W4283069360 creator A5015902606 @default.
• W4283069360 creator A5016776205 @default.
• W4283069360 creator A5021743410 @default.
• W4283069360 creator A5029131333 @default.
• W4283069360 creator A5030071794 @default.
• W4283069360 creator A5030219128 @default.
• W4283069360 creator A5043179726 @default.
• W4283069360 creator A5050917394 @default.
• W4283069360 creator A5051477764 @default.
• W4283069360 creator A5052970110 @default.
• W4283069360 creator A5053283797 @default.
• W4283069360 creator A5056016950 @default.
• W4283069360 creator A5060428819 @default.
• W4283069360 creator A5061425195 @default.
• W4283069360 creator A5064861218 @default.
• W4283069360 creator A5066582790 @default.
• W4283069360 creator A5067019998 @default.
• W4283069360 creator A5070225079 @default.
• W4283069360 creator A5080287202 @default.
• W4283069360 creator A5083823258 @default.
• W4283069360 creator A5085504317 @default.
• W4283069360 creator A5085542738 @default.
• W4283069360 creator A5087164805 @default.
• W4283069360 creator A5088298881 @default.
• W4283069360 creator A5088832294 @default.
• W4283069360 date "2022-06-18" @default.
• W4283069360 modified "2023-10-06" @default.
• W4283069360 title "Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunction syndrome: a randomized clinical trial" @default.
• W4283069360 cites W1941901208 @default.
• W4283069360 cites W1965929258 @default.
• W4283069360 cites W2098019283 @default.
• W4283069360 cites W2100536943 @default.
• W4283069360 cites W2102856718 @default.
• W4283069360 cites W2131345386 @default.
• W4283069360 cites W2144537497 @default.
• W4283069360 cites W2168456558 @default.
• W4283069360 cites W2171284117 @default.
• W4283069360 cites W2177407033 @default.
• W4283069360 cites W2338943353 @default.
• W4283069360 cites W2557169014 @default.
• W4283069360 cites W2761004909 @default.
• W4283069360 cites W2782135811 @default.
• W4283069360 cites W2792364673 @default.
• W4283069360 cites W2914455493 @default.
• W4283069360 cites W2977322360 @default.
• W4283069360 cites W2977556556 @default.
• W4283069360 cites W2992739672 @default.
• W4283069360 cites W2998853022 @default.
• W4283069360 cites W3012763772 @default.
• W4283069360 cites W3033872389 @default.
• W4283069360 cites W3036684707 @default.
• W4283069360 cites W3082355253 @default.
• W4283069360 cites W3193838886 @default.
• W4283069360 cites W3214720083 @default.
• W4283069360 cites W371461304 @default.
• W4283069360 cites W4233317660 @default.
• W4283069360 doi "https://doi.org/10.1186/s13054-022-04055-4" @default.
• W4283069360 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35717241" @default.
• W4283069360 hasPublicationYear "2022" @default.
• W4283069360 type Work @default.
• W4283069360 citedByCount "6" @default.
• W4283069360 countsByYear W42830693602022 @default.
• W4283069360 countsByYear W42830693602023 @default.
• W4283069360 crossrefType "journal-article" @default.
• W4283069360 hasAuthorship W4283069360A5002694006 @default.
• W4283069360 hasAuthorship W4283069360A5005343190 @default.
• W4283069360 hasAuthorship W4283069360A5015751415 @default.
• W4283069360 hasAuthorship W4283069360A5015902606 @default.
• W4283069360 hasAuthorship W4283069360A5016776205 @default.
• W4283069360 hasAuthorship W4283069360A5021743410 @default.
• W4283069360 hasAuthorship W4283069360A5029131333 @default.
• W4283069360 hasAuthorship W4283069360A5030071794 @default.
• W4283069360 hasAuthorship W4283069360A5030219128 @default.
• W4283069360 hasAuthorship W4283069360A5043179726 @default.
• W4283069360 hasAuthorship W4283069360A5050917394 @default.
• W4283069360 hasAuthorship W4283069360A5051477764 @default.
• W4283069360 hasAuthorship W4283069360A5052970110 @default.
• W4283069360 hasAuthorship W4283069360A5053283797 @default.
• W4283069360 hasAuthorship W4283069360A5056016950 @default.
• W4283069360 hasAuthorship W4283069360A5060428819 @default.
• W4283069360 hasAuthorship W4283069360A5061425195 @default.
• W4283069360 hasAuthorship W4283069360A5064861218 @default.
• W4283069360 hasAuthorship W4283069360A5066582790 @default.
• W4283069360 hasAuthorship W4283069360A5067019998 @default.
• W4283069360 hasAuthorship W4283069360A5070225079 @default.
• W4283069360 hasAuthorship W4283069360A5080287202 @default.
• W4283069360 hasAuthorship W4283069360A5083823258 @default.
• W4283069360 hasAuthorship W4283069360A5085504317 @default.
• W4283069360 hasAuthorship W4283069360A5085542738 @default.
• W4283069360 hasAuthorship W4283069360A5087164805 @default.
• W4283069360 hasAuthorship W4283069360A5088298881 @default.
• W4283069360 hasAuthorship W4283069360A5088832294 @default.
• W4283069360 hasBestOaLocation W42830693601 @default.
• W4283069360 hasConcept C126322002 @default.
• W4283069360 hasConcept C142724271 @default.

• next